Interacting Drugs |
Prazosin vs Linagliptin |
Security Level |
 |
Mechanism |
Linagliptin: P-glycoprotein/ABCB1 Inducers may decrease the serum concentration of Linagliptin. |
Management |
Strongly consider using an alternative to any strong P-glycoprotein inducer in patients who are being treated with linagliptin. If this combination is used, monitor patients closely for evidence of reduced linagliptin effectiveness. |
Prazosin vs Linagliptin
Post Review about Prazosin vs Linagliptin Click here to cancel reply.
Other Interactions of Prazosin
Other Interactions of Linagliptin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.